Physician profile
Frederick M David
NPI 1255313565
$407.46
in general payments reported to CMS, 2019-2025
9 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.54 · 2021: $53.44 · 2022: $67.33 · 2023: $32.43 · 2024: $106 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $129.41 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Eisai INC. | $65.16 | 2020-2021 | |
| Tempus Ai, INC | $53.19 | 2025 | Xt Cdx |
| Biotissue Holdings INC. | $36.93 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.75 | 2025 | Fruzaqla |
| Daiichi Sankyo INC. | $32.26 | 2021-2024 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.40 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.86 | 2023 | Farxiga |
| Genentech USA, INC. | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.